ロード中...
Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
High-dose chemotherapy supported by autologous stem cell support/transplantation (HDT/ASCT) has been a standard of care over the last two decades in patients with relapsed or refractory(R/R) diffuse large B-cell lymphoma (DLBCL), which is sensitive to salvage chemotherapy. HDT/ASCT for high-risk DLB...
保存先:
| 出版年: | J Clin Exp Hematop |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
JSLRT
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144205/ https://ncbi.nlm.nih.gov/pubmed/27980299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.100 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|